Pasar al contenido principal

Identifican la unión de dos proteínas como biomarcador del Alzheimer

IRB Barcelona en los medios
20 Abr 18

Images

Participantes

Imagen
Natalia Carulla
Research Associate
Tel.+34 93 40 37123

Contact

Imagen
Communication Officer
Tel.+34 93 40 37255

Europa Press, El Economista, Technology Networks, News Medical, entre otros medios de comunicación nacionales e internacionales, han publicado un artículo sobre un trabajo liderado en el IRB Barcelona que aporta la primera evidencia directa de dímeros (unión de dos proteínas) de beta-amiloide en enfermos de Alzheimer y señala su potencial como  biomarcador.

Enlace a Europa Press

Enlace a El Economista

Enlace a Technology Networks

Enlace a News Medicals

About IRB Barcelona

Created in 2005 by the Generalitat de Catalunya (Government of Catalonia) and University of Barcelona, IRB Barcelona is a Severo Ochoa Centre of Excellence, a seal that was awarded in 2011. The institute is devoted to conducting research of excellence in biomedicine and to transferring results to clinical practice, thus improving people’s quality of life, while simultaneously promoting the training of outstanding researchers, technology transfer, and public communication of science. Its 28 laboratories and eight core facilities address basic questions in biology and are orientated to diseases such as cancer, metastasis, Alzheimer’s, diabetes, and rare conditions. IRB Barcelona is an international centre that hosts 400 employees and more than 30 nationalities. It is located in the Barcelona Science Park. IRB Barcelona is a CERCA center, and a member of the Barcelona Institute of Science and Technology (BIST).